뇌질환의 혁신, 뉴로벤티(NeuroVenti)

NEWS

Here's the news about NeuroVenti

News/Notice

A place to promote the development of the pharmaceutical industry open…

페이지 정보

조회 412회 작성일 21-04-22

본문

A place to promote the development of the pharmaceutical industry opens.

21-04-22


The Pharmaceutical Society held the Spring International Conference from the 22nd to the 23rd... Exchange of latest research trends and achievements in each field


From the 22nd to the 23rd, the Korean Pharmaceutical Society will hold the 2021 Spring International Conference online under the theme of ‘The New Normal Era’s New Drug Development Journey through Industry-University Cooperation’.


First, a presentation on the latest research trends of domestic new drug development bio ventures is scheduled.

Looking in detail, Park Hee-dong, CEO of Innovo Therapeutics, introduces a new method of synthetic drug research using AI. Professor Jeon Yeong-ho of the College of Pharmacy at Korea University gave a speech on new methods and applications for discovering protein interaction inhibitors, and Professor Nam-joong Kim of Kyung Hee University College of Pharmacy gave a speech on the development of innovative new drugs through strategies to inhibit the entry of HBV (Hepatitis B Virus), a virus that causes chronic hepatitis B. Following this, Genosco CEO Koh Jong-seong plans to present a keynote speech based on his experiences while inventing the 19th domestic new drug, Zemiglo, and the 31st, Recraza.


On the 23rd, Seong Baek-rin, head of the Vaccine Commercialization Technology Development Project Group, plans to open the door with the theme of “Vaccine Sovereignty and Trends in Innovative Vaccine Technology for Global Advancement.”

The current status of development of COVID-19 vaccines and treatments for domestic pharmaceutical companies is also expected to be discussed.

Looking in detail, Dr. Tae-Kwon Oh of Cellid introduced the development process of AdCLD-CoV19, a Covid-10 vaccine based on adenovirus, and Joo-mi Han, director of Daewoong Pharmaceutical's center, focused on recreating anti-inflammatory drugs. will be announced. In addition, Shinpoong Pharmaceutical's Research Director Joo Cheong introduces the drug development strategy through drug re-creation of Pyramax, a malaria treatment.


In addition, lectures related to new drug development are prepared. The topics are largely related to startup-led new drug development and new drug development using big data and artificial intelligence.

New drug development by startups ▲ KAIST Professor Chul-Hee Choi (Ilias Biologics) new drug development paradigm for undruggable targets ▲ Professor Chan-Young Shin (Neuroventi) of Konkuk University Research and development for pre-clinical and clinical entry ▲ National Cancer Center Hyun-cheol Jang Research trends on the development of new strategies for anti-cancer drugs that induce differentiation of solid cancer by Dr. Han-Woong Lee of Yonsei University (GEMCRO) are included.

For the application of big data and artificial intelligence, ▲ AI techniques for chemical and genome space exploration ▲ Research on multi-omics-based precise diagnosis of diabetes complications ▲ Establishment of a cloud platform for new drug development based on big data/AI ▲ Big data and AI Drug design and new drug development using

List
NeuroVenti, Inc. 4th FL, 15, Seolleung-ro 121-gil, Gangnam-gu, Seoul, Republic of Korea
TEL : 82-2-540-5630 FAX : 82-2-548-5630 E-mail : contact@neuroventi.com

Copyright © 2024 뇌질환의 혁신, 뉴로벤티(NeuroVenti). All Rights Reserved.

Privacy Policy

×
'NeuroVenti' ("Company") places great importance on customers' personal information and wants to let customers know that it complies with the personal information protection regulations in the relevant law such as Personal Information Protection Act, Telecommunications Business Act, Protection of Communications Secrets Act based on Korean laws as well as how and for what purpose the personal information provided by customers is used and what measures are being taken to protect personal information through Company's policy on personal information handling

1. Personal lnformation Items to be Collected
Company collects and stores minimum and necessary information for providing its services to the member. The described information is collected in the following situations below.

- Information: Name, e-mail address, phone number
- collection method : Web site

2. Personal lnformation Collection and lts Purpose
Company collects personal information for the following purpose, and all personal information will only be collected with your consent.
-To make inquiries and responses in respect of contract execution and service provision.

3. Retention of Personal lnformation and Period of Its Use
After collecting personal information and achieving the purpose of its use, without exceptions, Company destroys the information immediately. For the following information only, however, Company retains them for the indicated period for the following reasons
- When the answer was completed

4. Provision of Personal Information
In principle, Company does not provide the personal information of users to the outside except in cases where the user has consent or is subject to the provisions of relevant laws and regulations. Note, however, that the following cases are exceptions.
- When the user agreed in advance
- When delivering sample collection kit
* Name of delivery service company: Fedex, UPS, DHL, etc
-If there is a request in accordance with the provisions of the law or the procedure and method prescribed by the law for the purpose of investigation
-If it is necessary for statistics, academic research, or market research and only when if it is provided in a form that cannot be identified

5. Destruction Process and Method of Personal Information
In principle, after collecting personal information and achieving the purpose of its use, Company destroys the information immediately without exceptions. The destruction process and method are as follows
1) Destruction Process
The information inputted by the user for membership, etc, shall be moved to a separate DB (in case of paper, separate document file) after the purpose of its use is achieved. It shall be destroyed after being retained for a certain period according to Company's internal policy and the reason for information protection based on the relevant laws (refer to Retention of Personal lnformation and Period of its Use")
2) Destruction Method Personal information printed out in paper shall be shredded by the shredder or incinerated. Personal information saved in electronic file form shall be deleted by a technical method that renders the records irreproducible.

6. Technical/Managerial Protection Measure for Personal Information
Company considers the following technical/managerial measures for securing safety to prevent loss, theft, leak, falsification or damage when handling personal information

7. Regarding the Installation, Operation, and Refusal of Automatic Collection Device of Personal Information
Company operates "cookies," which frequently save and find the information of the user. A cookie is a small text file sent by the server operating the website to the browser of the user and is saved on hard disk. Company uses cookies for the following purposes
A. Purpose of Use of Cookies
- In order to provide personalized services on your next visit, Company tracks the information on the web pages that you visit and browse with interest
- Cookies are used as resources to provide differentiated opportunities for participating in Company's events based onyour number of visits and to provide differentiated information according to individual interests.
The user has a choice with regard to cookie installation on the website he/she visited. Therefore, the user can permit cookies, check and confirm whenever cookies are saved, or refuse to save cookies by setting the option on the web browser.
B. Setting Method of Cookie (Permit/Refuse
The user can permit cookies, check and confirm whenever a cookies are saved, or refuse to save cookies by setting the option in the web browser.
Example of Setting Method (in the case of Internet Explorer) : Tool in the upper part of the web browser >Internet Options >Personal Information Tab >Setting the Personal information Handling Level When the user refuses cookie installation, providing services requiring login may be difficult.

8. Customer Complaint Handling Service Regarding Personal Information
Company has designated the following department and person in charge of personal information management to protect the personal information of customers and to handle complaints regarding personal information.
You may report all complaints related to personal information from your use of our services to the personal information management manager or department. Company will respond promptly and adequately to your complaints. If you need to report or consult about other privacy infringement, please contact the following organizations.

- Korean internet & Security Agency (privacy.kisa.or.kr / +82-2-405-5118)
- ePRIVACY (www.eprivacy.or.kr / +82-2-580-0533 ~ 4)
- Supreme Prosecutors' Office (www.spo.go.kr / +82-2-3480-2000)
- Korean National Police Agency Cyber Bureau (cyberbureau.police.go.kr / +82-2-392-0330)

I agree to the privacy policy.

이용안내

×
내용이 나옵니다.